Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
Clinical trial NCT05981131 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05981131
- Sponsor
- ImmunityBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-17
- Primary completion
- 2033-08-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.